Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
4.540
+0.040 (0.89%)
Nov 9, 2026, 4:00 PM EST - Market closed
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $9.56 million as of November 9, 2026. It is the 41,613th most valuable company in the world and the 5,592nd biggest in the United States. Its market cap has decreased by 54.67% in one year.
Market Cap
9.56M
Enterprise Value
6.03M
1-Year Change
-54.67%
Global Rank
Country Rank
#5,592 United States
Category
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $9.56M, a decrease of -47.45%. That is a compound annual growth rate of -10.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 7.40M | -45.99% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 9.89M |
| Intensity Therapeutics | 9.79M |
| Chemomab Therapeutics | 9.56M |
| MetaVia | 9.42M |
| BioLineRx | 9.35M |
| Phio Pharmaceuticals | 9.31M |
| CalciMedica | 9.29M |
| Lisata Therapeutics | 9.28M |